Clinical Trial Update: Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of S-1 in locally advanced or metastatic pancreatic cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Locally Advanced or Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-12-10